- Home
- HRTX vs SABA Comparison
HRTX vs SABA Comparison
Compare HRTX & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- SABA
- Stock Information
- Founded
- HRTX 1983
- SABA 1988
- Country
- HRTX United States
- SABA United States
- Employees
- HRTX N/A
- SABA N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- SABA
- Sector
- HRTX Health Care
- SABA
- Exchange
- HRTX Nasdaq
- SABA Nasdaq
- Market Cap
- HRTX 276.1M
- SABA 254.3M
- IPO Year
- HRTX 1987
- SABA N/A
- Fundamental
- Price
- HRTX $1.33
- SABA $9.29
- Analyst Decision
- HRTX Strong Buy
- SABA
- Analyst Count
- HRTX 2
- SABA 0
- Target Price
- HRTX $4.50
- SABA N/A
- AVG Volume (30 Days)
- HRTX 2.2M
- SABA 290.0K
- Earning Date
- HRTX 08-08-2025
- SABA 01-01-0001
- Dividend Yield
- HRTX N/A
- SABA 12.91%
- EPS Growth
- HRTX N/A
- SABA N/A
- EPS
- HRTX N/A
- SABA N/A
- Revenue
- HRTX $149,694,000.00
- SABA N/A
- Revenue This Year
- HRTX $12.08
- SABA N/A
- Revenue Next Year
- HRTX $12.57
- SABA N/A
- P/E Ratio
- HRTX N/A
- SABA N/A
- Revenue Growth
- HRTX 9.78
- SABA N/A
- 52 Week Low
- HRTX $1.04
- SABA $3.64
- 52 Week High
- HRTX $2.68
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- HRTX 28.25
- SABA 51.93
- Support Level
- HRTX $1.31
- SABA $9.17
- Resistance Level
- HRTX $1.47
- SABA $9.35
- Average True Range (ATR)
- HRTX 0.11
- SABA 0.12
- MACD
- HRTX -0.04
- SABA -0.01
- Stochastic Oscillator
- HRTX 19.72
- SABA 42.76
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.